Solid sequential growth expected in 2Q

Research evidence excerpt

Solid sequential growth expected in 2Q

alysis and drafting of

research content. However, duly qualified research analysts are ultimately responsible for all content and recommendations contained in Macquarie's research reports.

Country-specific disclaimers:

Australia: In Australia, research is issued and distributed by Macquarie Securities (Australia) Ltd (AFSL No. 238947), a participating organization of the Australian Securities

Exchange. Macquarie Securities (Australia) Limited staff involved with the preparation of research have regular interaction with companies they cover. Additionally,

Macquarie Group Limited does and seeks to do business with companies covered by Macquarie Research. There are robust information barriers in place to protect the

independence of Macquarie Research’s product. However, recipients of Macquarie Research should be aware of this potential conflict of interest. New Zealand: In New

Zealand, research is issued and distributed by Macquarie Securities (NZ) Ltd, a NZX Firm. United Kingdom and the EEA: In the United Kingdom and the European

Economic Area, research is distributed by Macquarie Capital (Europe) Ltd, which is authorised and regulated by the Financial Conduct Authority (No. 193905). Hong

Kong & Mainland China: In Hong Kong, research is issued and distributed by Macquarie Capital Limited, which is licensed and regulated by the Securities and Futures

Commission. Only non-A share research is distributed into Mainland China by Macquarie Capital Limited. Japan: In Japan, research is issued and distributed by Macquarie

Capital Securities (Japan) Limited (Tokyo Branch), the Financial Instruments Business Operator, registered with the Financial Services Agency (Registration number:

Kanto Financial Bureau (FIBO) No.